Research Committee

Oracle's Research Committee comprises of experts in the field of head and neck cancer, pharmaceuticals as patient representatives who help shape and deliver our research strategy to maximise the charity's impact in Head and Neck Cancer.

The Committee is Chaired by Oncologist Teresa Urbano-Guerrero.

The Research Committee help define Oracle's Research Strategy and ensure that the research Oracle funds is at the forefront of head and neck cancer research.  As members of AMRC, Oracle is bound by the following mandatory requirements:

  • Publish a research strategy
  • A written conflicts of interest policy
  • Commit to the three R's with the use of animals in medical research
  • Follow the five principles of peer review
    • Accountability
    • Balance
    • Independence
    • Rotation
    • Impartiality

Teresa Guerrero Urbano
Consultant Clinical Oncologist


Keith Jones
Financier and lay person
Committee Member

Ketan Shah

Ketan Shah
Consultant Clinical Oncologist
Committee Member

Stuart Winter_highres

Stuart Winter
Consultant ENT Surgeon
Committee Member

Niran Nistala

Kiran Nistala
VP and Head of Clinical Development, Immunology, Respiratory & Immunology Late-stage Development, AstraZeneca
Committee Member


Dr Kate Newbold
Consultant Clinical Oncologist
Committee Member

2013_Feb27-Mar20 Baikal Neutrino-LENA photo - 081

Professor Anson Mackay
Emeritus Professor at University College London
Committee Member

Help us beat cancer

Our life-saving work relies on the money you give us.

Donate now and together we can save more lives by beating cancer sooner.

Follow us

Get in touch

Call 0203 475 3471



Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS